Your institution may have rights to this item. Sign in to continue.
Title
Discontinuation of Spectinomycin.
Abstract
Reports on the decision of Pfizer, Inc. to discontinue the distribution of spectinomycin in the U.S. Disease being treated by spectinomycin; Indications that exist for which spectinomycin is the preferred treatment option for Neisseria gonorrhoeae.